Pfizer offers cut-price pneumonia shot for humanitarian crises

LONDON (Reuters) - U.S. pharmaceuticals giant Pfizer is to offer its pneumococcal vaccine at the lowest possible price to non-governmental organizations seeking to protect vulnerable people from illness in humanitarian crises.